Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression

Journal of Hepatology

Volumn 31, Issue 1, 1999, Pages 39-46

  Pratiwi, Rarastoeti ^a   Fletcher, Linda M ^a   Pyper, Wendy R ^a   Do, Kim Anh ^a   Crawford, Darrell H G ^a   Powell, Lawrie W ^a   Jazwinska, Elizabeth C ^a  

^a NONE

Author keywords

HHC clinical expression; Iron overload; Modifying genes

Indexed keywords

FERRITIN; IRON; MICROSATELLITE DNA; TRANSFERRIN;

AMINO ACID SUBSTITUTION; ARTICLE; AUSTRALIA; CHROMOSOME 6P; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SEX DIFFERENCE;

EID: 0032992157     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80161-5     Document Type: Article

References (44)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC classl-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
2. Kerem B, Rommen JM, Buchanan JA, Markiewiccz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 245:1989;1073-1080.
3. Huntington's Disease Collaboration Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
4. Hastbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, Daly M, et al. The diastropic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell. 78:1994;1073-1087.
5. Hill WG, Weir BS. Maximum-likehood estimation of gene location by linkage disequilibrium. Am J Hum Genet. 54:1994;705-714.
6. Risch N, Devlin B. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 29:1995;311-322.
7. Gasparini P, Borgato L, Piperno A, Girelli D, Oliveri O, Gottardi E, et al. Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F. Hum Mol Genet. 2:(5):1993;571-576.
8. Jazwinska EC, Lee SC, Webb SI, Halliday JW, Powell LW. Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet. 53:1993;347-352.
9. Stone C, Pointon J, Jazwinska EC, Halliday JW, Powell LW, Robson KJH, et al. Isolation of CA dinucleotide repeats close to D6S105; linkage disequilibrium with haemochromatosis. Hum Mol Genet. 3:1994;2043-2046.
10. Gandon G, Jouanolle AM, Chauvel B, Mauvieux V, Le Treut A, Feingold J, et al. Linkage disequilibrium and extended haplotypes in the HLA-A to D6S105 region: implications for mapping the hemochromatosis gene (HFE). Hum Genet. 97:1996;103-113.
11. Raha-Chowdhury R, Bowen DJ, Stone C, Pointon JJ, Terwilliger JD, Shearman JD, et al. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet. 4:1995;1869-1874.
12. Beutler E, West C, Gelbart T, Felitti VJ. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatability complex are responsible for hemochromatosis. Commentary. Blood Cells Molecules and Diseases. 23:1997;145a-145b.
13. Aguilar-Martinez PA, Biron C, Blanc F, Masmejean C, Jeanjean P, Michel H, et al. Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease? Blood Cells Molecules and Diseases. 23:1997;269-276.
14. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet. 61:1997;762-764.
15. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 60:1997;828-832.
16. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW. Haemochromatosis and HLA-H. Nat Genet. 14:1996;249-251.
17. Jouanalle AM, Gandon G, Jezequel P, Blayau M, Campion ML. Hemochromatosis and HLA-H. Nat Genet. 14:1996;251-252.
18. Powell LW, Summers KM, Board PG, Axelsen E, Webb S, Halliday JW. Expression of hemochromatosis in homozygous subjects, implication for early diagnosis and prevention. Gastroenterology. 98:1990;1625-1632.
19. Crawford DHG, Halliday JW, Summers KM, Bourke MJ, Powell LW. Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominant genetic effect on iron storage. Hepatology. 17:1993;833-837.
20. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 87:1984;628-633.
21. Moirand D, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 127:1997;105-110.
22. Barton JC, Harmon L, Rivers C, Acton RT. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells, Molecules, and Diseases. 15:1996;195-204.
23. Crawford DHG, Powell LW, Leggett BA, Francis JS, Fletcher LM, Webb SI, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet. 57:1995;362-367.
24. Jazwinska EC, Pyper WR, Burt MJ, Francis JL, Goldwurm S, Webb SI, et al. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet. 56:1995;428-433.
25. Piperno A, Arosio C, Fargion S, Roetto A, Nicolli C, Girelli D, et al. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology. 24:1996;43-46.
26. Jazwinska EC, Powell LW. Hemochromatosis and"HLA-H": Definite! Hepatology. 25:1997;495-496.
27. Mura C, Nousbaum JB, Verger P, Moalic MT, Raguenes O, Mercier AY, et al. Phenotype-genotype correlation in haemochromatosis subjects. Hum Genet. 101:1997;271-276.
28. Barton JC, Shih WWH, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompability complex are responsible for hemochromatosis. Blood Cells, Molecules and Diseases. 30:1997;135-145.
29. Kirkwood BR. Essentials of Medical Statistics. Oxford, London, Edinburgh, Boston, Palo Alto, Melbourne: Blackwell Scientific Publications; 1988. p. 87-105, 173-9.
30. SAS Institute. SAS User's Guide, Version, 6th ed. 1997;SAS Institute Inc, Cary, N.C.
31. Banyer JL, Goldrum S, Cullen L, Van Der Griend B, Zournazi A, Smit DJ, et al. The spinal muscular atrophy gene region at 5q13.1 has a paralogous chromosomal region at 6p21.3. Mamm Genome. 9:1998;235-239.
32. Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE. Deletion in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet. 4:1995;631-634.
33. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis. Hepatology. 6:1986;24-29.
34. Summers KM, Halliday JW, Powell LW. Identification of homozygous haemochromatosis subjects by measurement of hepatic iron index. Hepatology. 12:1990;20-25.
35. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficiency of hepatic tissue iron index in differing genetic haemochromatosis from alcoholic haemosiderosis. Gut. 32:1991;207-210.
36. Adams PC, Bradley C, Henderson AR. Evaluation of the hepatic iron index as a diagnostic criterion for genetic hemochromatosis. J Lab Clin Med. 130:1997;573-574.
37. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 93:1998;111-113.
38. Feder JN, Penny DM, Irrinike A, Lee VK, Lebron JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA. 95:1998;1472-1477.
39. 2-microglobulin interaction and cell surface expression. J Biol Chem. 272:1997;14025-14028.
40. 2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA. 94:1997;12384-12389.
41. Zhou X, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA. 95:1998;2492-2497.
42. Bonyadi M, Rusholme SAB, Cousins FM, Su HC, Biron CA, Farrall M, et al. Mapping of a major genetic modifier of embrionic lethality in TGF1 knockout mice. Nat Genet. 15:1997;207-211.
43. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet. 12:1996;280-287.
44. Neumann PE, Frankel WN, Letts VA, Coffin JM, Copp AJ, Berfield M. Multifactorial inheritance of neural tube defects: localization of the major gene and recombination of modifiers in ct mutant mice. Nat Genet. 6:1994;357-362.